Reaction

Viral Upper Respiratory Tract Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,725 reports · 155 co-occurring drugs

As of the last recalculation, Viral Upper Respiratory Tract Infection appears in 4,725 FAERS reports alongside 155 co-occurring drug terms. The strongest observed disproportionality signal is METHYLPREDNISOLONE ACETATE (PRR 35.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Methylprednisolone Acetate	64	35.7	36.0
Diphenhydramine Hydrochloride Capsule, Liquid Filled	65	13.6	13.6
Hydroxychloroquine Sulfate	215	10.8	10.9
Hydroxychloroquine	171	10.4	10.5
Lumacaftor And Ivacaftor	19	9.8	9.8
Ciclesonide	27	8.8	8.8
Leflunomide	184	8.0	8.0
Tocilizumab	197	7.9	7.9
Palivizumab	26	7.5	7.5
Eculizumab	89	7.3	7.3
Meloxicam	94	7.3	7.3
Human Immunoglobulin G	32	6.9	6.9
Diclofenac	131	6.9	6.9
Abatacept	203	6.7	6.7
Mepolizumab	72	6.5	6.5
Cyanocobalamin	47	6.3	6.3
Ivacaftor	11	6.1	6.1
Fluticasone Propionate And Salmeterol Xinafoate	76	5.6	5.7
Tofacitinib	219	5.4	5.4
Epoprostenol	15	5.1	5.1
Tranexamic Acid	10	5.0	5.0
Sildenafil Powder,	39	4.9	4.9
Cholestyramine	13	4.7	4.8
Etanercept	564	4.6	4.6
Mometasone	19	4.6	4.6
Alemtuzumab	20	4.6	4.6
Golimumab	87	4.5	4.5
Omalizumab	86	4.5	4.5
Dornase Alfa	20	4.5	4.5
Methotrexate	400	4.5	4.5
Diclofenac Sodium	148	4.4	4.4
Montelukast Sodium	119	4.4	4.4
Atovaquone	8	4.4	4.4
Rituximab	202	4.4	4.4
Metolazone	11	4.3	4.3
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin	20	4.3	4.3
Naproxen Sodium, Pseudoephedrine Hydrochloride	20	4.3	4.3
Selexipag	25	4.3	4.3
Bosentan	48	4.2	4.2
Methotrexate Sodium	431	4.2	4.2
Acetaminophen, Chlorpheniramine Maleate, Phenylephrine Hcl	46	4.1	4.1
Alendronate Sodium Tablet	17	4.1	4.1
Fludarabine Phosphate	35	3.9	3.9
Riociguat	29	3.9	3.9
Sirolimus	12	3.9	3.9
Cetirizine Hcl	8	3.8	3.8
Mometasone Furoate	36	3.8	3.8
Fluticasone Furoate And Vilanterol Trifenatate	31	3.8	3.8
Oseltamivir Phosphate	21	3.8	3.8
Diphenhydramine	54	3.8	3.8
Itraconazole	10	3.8	3.8
Budesonide And Formoterol Fumarate Dihydrate	82	3.8	3.8
Sildenafil	49	3.8	3.8
Basiliximab	10	3.8	3.8
Trimethoprim	10	3.7	3.7
Thiotepa	8	3.7	3.7
Canakinumab	9	3.7	3.7
Polyethylene Glycol	9	3.7	3.7
Vigabatrin	12	3.6	3.6
Belimumab	26	3.6	3.6
Mercaptopurine	14	3.6	3.6
Patiromer	11	3.5	3.5
Thiamine Hydrochloride, Riboflavin 5 Phosphate Sodium, Dexpanthenol And Niacinamide	24	3.5	3.5
Guaifenesin	24	3.5	3.5
Iron	52	3.5	3.5
Indapamide	14	3.4	3.4
Umeclidinium	7	3.4	3.4
Etonogestrel And Ethinyl Estradiol	17	3.4	3.4
Alirocumab	19	3.3	3.3
Macitentan	52	3.3	3.3
Acetaminophen, Guaifenesin, And Phenylephrine Hydrochloride	117	3.3	3.3
Valganciclovir	14	3.3	3.3
Valganciclovir Hydrochloride	14	3.3	3.3
Fingolimod Hcl	63	3.2	3.2
Celecoxib	93	3.2	3.2
Ado-Trastuzumab Emtansine	6	3.1	3.1
Albuterol Sulfate	204	3.1	3.1
Biotin	22	3.1	3.1
Adrenalinum	29	3.1	3.1
Asfotase Alfa	7	3.1	3.1
Ixazomib	20	3.1	3.1
Lisinopril And Hydrochlorothiazide	7	3.0	3.0
Sildenafil Citrate	86	3.0	3.0
Bumetanide	18	3.0	3.0
Fluticasone Propionate	87	3.0	3.0
Carfilzomib	19	3.0	3.0
Ursosiol	13	3.0	3.0
Acyclovir	75	2.9	2.9
Infliximab-Dyyb	19	2.9	2.9
Tiotropium Bromide	87	2.8	2.8
Epinephrine	41	2.8	2.8
Secukinumab	99	2.7	2.7
Modafinil	20	2.7	2.7
Naltrexone	19	2.7	2.7
Valacyclovir Hydrochloride	43	2.7	2.7
Loratadine Oral	30	2.7	2.7
Tofacitinib Citrate	8	2.7	2.7
Benzonatate	10	2.7	2.7
Dexlansoprazole	25	2.6	2.7
Ticagrelor	19	2.6	2.6
Levocetirizine Dihydrochloride	14	2.6	2.6
Doxorubicin Hydrochloride	19	2.6	2.6
Tobramycin	14	2.6	2.6
Blinatumomab	6	2.5	2.5
Clobazam	14	2.5	2.5
Dofetilide	6	2.5	2.5
Rucaparib	5	2.5	2.5
Azelastine	10	2.5	2.5
Bimatoprost	16	2.5	2.5
Tadalafil	55	2.4	2.4
Ambrisentan	68	2.4	2.4
Sodium Oxybate	36	2.4	2.4
Vincristine Sulfate	16	2.4	2.4
Adalimumab	368	2.4	2.4
Peginterferon Beta-1A	7	2.4	2.4
Daratumumab	21	2.3	2.3
Pancrelipase	20	2.3	2.3
Erlotinib	5	2.3	2.3
Fexofenadine Hydrochloride	11	2.2	2.2
Palbociclib	48	2.2	2.2
Botulinum Toxin Type A	6	2.1	2.1
Cannabidiol	11	2.1	2.1
Pomalidomide	48	2.1	2.1
Ledipasvir And Sofosbuvir	9	2.1	2.1
Lisdexamfetamine Dimesylate	15	2.0	2.0
Mometasone Furoate And Formoterol Fumarate Dihydrate	7	2.0	2.0
Lenalidomide	186	2.0	2.0
Apremilast	63	1.9	1.9
Certolizumab Pegol	50	1.9	1.9
Lifitegrast	7	1.9	1.9
Treprostinil	53	1.9	1.9
Fluticasone Propionate And Salmeterol	17	1.8	1.8
Axicabtagene Ciloleucel	4	1.8	1.8
Ustekinumab	41	1.8	1.8
Erlotinib Hydrochloride	5	1.8	1.8
Ofatumumab	13	1.7	1.7
Velpatasvir And Sofosbuvir	5	1.7	1.7
Azacitidine For	7	1.7	1.7
Sunitinib Malate	15	1.7	1.7
Bortezomib	34	1.7	1.7
Trifluridine And Tipiracil	4	1.6	1.6
Ravulizumab	5	1.6	1.6
Umeclidinium Bromide And Vilanterol Trifenatate	6	1.6	1.6
Diclofenac Potassium, Film Coated	3	1.6	1.6
Diclofenac Potassium Tablets	3	1.6	1.6
Ruxolitinib	25	1.5	1.5
Natalizumab	63	1.5	1.5
Ocrelizumab	21	1.5	1.5
Isotretinoin	16	1.4	1.4
Elexacaftor, Tezacaftor, And Ivacaftor	4	1.4	1.4
Evolocumab	51	1.4	1.4
Dimethyl Fumarate	34	1.2	1.2
Ixekizumab	10	1.2	1.2
Guselkumab	7	0.9	0.9
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	6	0.9	0.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.